BGI-Backed Chinese Biotech Start-Up GenoImmune Raises $18M Series A Round

Chinese biotech start-up GenoImmune has secured RMB120 million (US$17.87 million) in a series A round of financing led by GF Xinde Investment Management Co., a private equity affiliate of GF Securities, said GenoImmune in a statement released on Wednesday. GenoImmune was founded in February 2017 in central China’s Wuhan city to specialize in the immunotherapy […]

BGI-Backed Chinese Biotech Start-Up GenoImmune Raises $18M Series A Round comes originally from China Money Network. All Rights Reserved.

Read the original article: China Money Network